Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Nicotinic receptors clinical effects

Some agonists, such as methacholine, carbachol and bethanecol are structurally very similar to ACh (Fig. 6.6). They are all more resistant to attack by cholinesterase than ACh and so longer acting, especially the non-acetylated carbamyl derivatives carbachol and bethanecol. Carbachol retains both nicotinic and muscarinic effects but the presence of a methyl (CH3) group on the p carbon of choline, as in methacholine and bethanecol, restricts activity to muscarinic receptors. Being charged lipophobic compounds they do not enter the CNS but produce powerful peripheral parasympathetic effects which are occasionally used clinically, i.e. to stimulate the gut or bladder. [Pg.128]

Unlike the muscarinic receptors, repeated exposure of the neuronal receptors to nicotine, both in vivo and in vitro, results in an increase in the number of receptors similar changes are reported to occur after physostigmine is administered directly into the cerebral ventricles of rats. These changes in the density of the nicotinic receptors are accompanied by an increased release of acetylcholine. Following the chronic administration of physostigmine, however, a desensitization of the receptors occurs. Functionally nicotinic receptors appear to be involved in memory formation in clinical studies it has been shown that nicotine can reverse the effects of scopolamine on short-term working memory and both... [Pg.41]

The direct-acting cholinomimetic drugs can be divided on the basis of chemical structure into esters of choline (including acetylcholine) and alkaloids (such as muscarine and nicotine). Many of these drugs have effects on both receptors acetylcholine is typical. A few of them are highly selective for the muscarinic or for the nicotinic receptor. However, none of the clinically useful drugs is selective for receptor subtypes in either class. [Pg.130]

Local anesthetics have poorly understood effects on inflammation at sites of injury, and these anti-inflammatory effects may contribute to improved pain control in some chronic pain syndromes. At the concentrations used in spinal anesthesia, local anesthetics can inhibit transmission via substance P (neurokinin-1), NMDA, and AMPA receptors in the secondary afferent neurons (Figure 26-1). These effects may contribute to the analgesia achieved by subarachnoid administration. Local anesthetics can also be shown to block a variety of other ion channels, including nicotinic acetylcholine channels in the spinal cord. However, there is no convincing evidence that this mechanism is important in the acute clinical effects of these drugs. High concentrations of local anesthetics in the subarachnoid space can interfere with intra-axonal transport and calcium homeostasis, contributing to potential spinal toxicity. [Pg.566]

In small doses, local anesthetics can depress posttetanic potentiation via a prejunctional neural effect. In large doses, local anesthetics can block neuromuscular transmission. With higher doses, local anesthetics block acetylcholine-induced muscle contractions as a result of blockade of the nicotinic receptor ion channels. Experimentally, similar effects can be demonstrated with sodium channel-blocking antiarrhythmic drugs such as quinidine. However, at the doses used for cardiac arrhythmias, this interaction is of little or no clinical significance. Higher concentrations of bupivacaine (0.75%) have been associated with cardiac arrhythmias independent of the muscle relaxant used. [Pg.589]

Galantamine, unlike the other anticholinesterases in clinical use, is derived from the alkaloids from the daffodil and snowdrop family. It is a reversible, competitive inhibitor of acetylcholinesterase with some inhibitory action on butyryl cholinesterase. It is also an agonist at nicotinic receptor sites. Although a clinically effective drug, galantamine frequently causes gastrointestinal side effects. [Pg.363]

Areca nut 1 Procydidine (used to control extrapyramidal -parkinsonian - with antipsychotic medications) Caused severe rigidity and jaw tremor. This is an established and clinically significant interaction Procydidine is an antimuscarinic agent, i.e. antagonizes the effects of ACh in one set of ACh receptors. Thus, herbal products used culturally with effects similar to ACh, e.g. areca nut will produce enhanced effects at other -nicotinic - receptors to produce adverse effects Avoid chewing betel nut (also found in prepared pan masala )... [Pg.755]


See other pages where Nicotinic receptors clinical effects is mentioned: [Pg.534]    [Pg.534]    [Pg.41]    [Pg.537]    [Pg.548]    [Pg.228]    [Pg.425]    [Pg.432]    [Pg.390]    [Pg.219]    [Pg.273]    [Pg.136]    [Pg.563]    [Pg.571]    [Pg.164]    [Pg.583]    [Pg.585]    [Pg.161]    [Pg.163]    [Pg.479]    [Pg.164]    [Pg.625]    [Pg.28]    [Pg.29]    [Pg.30]    [Pg.466]    [Pg.763]    [Pg.278]    [Pg.1893]    [Pg.192]    [Pg.762]    [Pg.885]    [Pg.382]    [Pg.19]    [Pg.22]    [Pg.25]    [Pg.26]    [Pg.103]    [Pg.424]    [Pg.278]    [Pg.71]   
See also in sourсe #XX -- [ Pg.202 , Pg.288 ]




SEARCH



Clinical effects

Nicotinates effects

Nicotine effects

Nicotinic effects

Nicotinic receptors

© 2024 chempedia.info